Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Accelerated and Adaptive Radiation Therapy for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03128008 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03128008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03128008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Accelerated and Adaptive Radiation Therapy for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
December 7, 2017
Completion date
January 27, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non small cell lung (nsclc)